Start free

Medifast Inc (MED) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 20, 2026.

Filings shown
14
Open-market buys
17
Open-market sells
2
Buys, 10b5-1 box not checked
17 of 17

Counts cover the 14 most recent Form 4 filings Tradune holds for MED (filed May 12 – Nov 20, 2026); the score below covers only the trailing 90 days (11 buys, 2 sells). SEC EDGAR Form 4 filings for MED last checked Nov 21, 2026, 09:00 UTC; the latest MED filing Tradune holds was filed Nov 20, 2026. This is not guaranteed to be the complete record — see MED's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 6 filings Tradune holds for MED filed Aug 26 – Nov 20, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

2 open-market sales by Rule 10b5-1 checkbox

On filings with the 10b5-1 box checked
2 sales· 19,089 sh
checkbox disclosed
On filings with the box not checked
0 sales· 0 sh
not proof that no plan exists
Not comparable
0 sales· 0 sh
filed before Apr 1, 2023, or no checkbox value in the filing data

Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Parsa KiaiDirector 11 0 147,733 — +$1,791,557
Daniel R. ChardDirector 0 2 — 19,089 −$226,289

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

56/ 100

Net insider purchases
1 distinct buyer11 buy · 2 sell txofficer buying

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at MED

Insiders reported 17 open-market purchases of MED between May 12, 2026 and Nov 20, 2026, across 2 distinct buyers. The most recent purchase was reported by Parsa Kiai (Director) on Nov 19, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Parsa Kiai Director · filed Nov 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 2,450 $12.05 23,795 (indirect) +11% Nov 19, 2026
Open-market purchase 10b5-1 box not checked 82,700 $12.05 804,221 (indirect) +11% Nov 19, 2026
Open-market purchase 10b5-1 box not checked 8,630 $12.16 721,521 (indirect) +1.2% Nov 18, 2026
Open-market purchase 10b5-1 box not checked 256 $12.16 21,345 (indirect) +1.2% Nov 18, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Parsa Kiai Director · filed Nov 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 661 $13.03 21,089 (indirect) +3.2% Nov 4, 2026
Parsa Kiai Director · filed Oct 30, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 158 $12.24 20,428 (indirect) +0.8% Oct 28, 2026
Open-market purchase 10b5-1 box not checked 5,399 $12.24 712,891 (indirect) +0.8% Oct 28, 2026
Daniel R. Chard Director · filed Sep 30, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 9,544 $11.73 130,609 (indirect) −6.8% Sep 29, 2026
Open-market sale 10b5-1 box checked 9,545 $11.98 140,153 (indirect) −6.4% Sep 28, 2026
Parsa Kiai Director · filed Aug 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 41,975 $12.26 707,492 (indirect) +6.3% Aug 26, 2026
Open-market purchase 10b5-1 box not checked 1,175 $12.26 20,270 (indirect) +6.2% Aug 26, 2026
Parsa Kiai Director · filed Aug 26, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 4,211 $12.00 665,517 (indirect) +0.6% Aug 24, 2026
Open-market purchase 10b5-1 box not checked 118 $12.00 19,095 (indirect) +0.6% Aug 24, 2026
Parsa Kiai Director · filed Aug 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 41,975 $11.60 661,306 (indirect) +6.8% Aug 20, 2026
Open-market purchase 10b5-1 box not checked 1,175 $11.60 18,977 (indirect) +6.6% Aug 20, 2026
Open-market purchase 10b5-1 box not checked 799 $11.66 17,802 (indirect) +4.7% Aug 19, 2026
Open-market purchase 10b5-1 box not checked 28,538 $11.66 619,331 (indirect) +4.8% Aug 19, 2026
Jeffrey Matthew Rose Director · filed May 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 11,680 — 11,680 — May 26, 2026
Grant / award 6,739 — 18,419 +58% May 26, 2026
Parsa Kiai Director · filed May 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 11,680 — 11,680 — May 26, 2026
Grant / award 7,637 — 19,317 +65% May 26, 2026
Andrea B. Thomas Director · filed May 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 11,680 — 35,697 +49% May 26, 2026
Scott Schlackman Director · filed May 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 11,680 — 42,229 +38% May 26, 2026
Elizabeth A. Geary Director · filed May 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 11,680 — 31,225 +60% May 26, 2026
Ming Xian Director · filed May 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Restricted Stock Units (cash settled) 11,680 — — — May 26, 2026
Scott Schlackman Director · filed May 12, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 2,500 $12.53 30,549 +8.9% May 11, 2026
Open-market purchase 10b5-1 box not checked 2,500 $12.65 28,049 +9.8% May 8, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to MED's (Nov 20, 2026).

Frequently asked about MED insider activity

How many insiders bought MED stock in these Form 4 filings?

2 distinct insiders at Medifast Inc reported 17 open-market purchases (Form 4 code P) of MED shares between May 12, 2026 and Nov 20, 2026, the most recent filed by Parsa Kiai (Director) on Nov 19, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Who filed the most recent Form 4 for MED?

The most recent Form 4 on this page was filed by Parsa Kiai (Director) on Nov 20, 2026, reporting 4 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market MED insider purchase shown?

The largest open-market purchase among the filings shown was 82,700 MED shares at $12.05 (about $996,237) by Parsa Kiai (Director) on Nov 19, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

Do the recent MED insider purchases have the Form 4 10b5-1 box checked?

No. All 17 MED open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Parsa Kiai (Director) on Nov 19, 2026, 82,700 shares.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for MED — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.